96 related articles for article (PubMed ID: 20039940)
1. Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease.
Infante J; García-Gorostiaga I; Sánchez-Juan P; Sierra M; Martín-Gurpegui JL; Terrazas J; Mateo I; Rodríguez-Rodríguez E; Berciano J; Combarros O
Eur J Neurol; 2010 May; 17(5):760-2. PubMed ID: 20039940
[TBL] [Abstract][Full Text] [Related]
2. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk.
Infante J; Rodríguez-Rodríguez E; Mateo I; Llorca J; Vázquez-Higuera JL; Berciano J; Combarros O
Neurobiol Aging; 2010 Apr; 31(4):710-4. PubMed ID: 18597895
[TBL] [Abstract][Full Text] [Related]
3. GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.
Kalinderi K; Fidani L; Katsarou Z; Clarimón J; Bostantjopoulou S; Kotsis A
Neurobiol Aging; 2011 Mar; 32(3):546.e1-5. PubMed ID: 19573950
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of heme oxygenase-1 and tau genetic variants on Alzheimer's disease risk.
Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Vázquez-Higuera JL; García-Gorostiaga I; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2008; 26(4):339-42. PubMed ID: 18841019
[TBL] [Abstract][Full Text] [Related]
5. GSK3β reduces risk of sporadic Parkinson's disease in ethnic Chinese.
Zhao DM; Li NN; Zhang JH; Chang XL; Mao XY; Liao Q; Tan EK; Peng R
Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):718-21. PubMed ID: 22815195
[TBL] [Abstract][Full Text] [Related]
6. Heme oxygenase-1 promoter polymorphisms and risk of spina bifida.
Fujioka K; Yang W; Wallenstein MB; Zhao H; Wong RJ; Stevenson DK; Shaw GM
Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):741-6. PubMed ID: 26173399
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients.
Funke C; Tomiuk J; Riess O; Berg D; Soehn AS
J Neural Transm (Vienna); 2009 Jul; 116(7):853-9. PubMed ID: 19475336
[TBL] [Abstract][Full Text] [Related]
8. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
[TBL] [Abstract][Full Text] [Related]
9. NFE2L2 variations reduce antioxidant response in patients with Parkinson disease.
Gui Y; Zhang L; Lv W; Zhang W; Zhao J; Hu X
Oncotarget; 2016 Mar; 7(10):10756-64. PubMed ID: 26887053
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors.
Kaneda H; Ohno M; Taguchi J; Togo M; Hashimoto H; Ogasawara K; Aizawa T; Ishizaka N; Nagai R
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1680-5. PubMed ID: 12377749
[TBL] [Abstract][Full Text] [Related]
11. The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis.
Yuan Y; Tong Q; Zhou X; Zhang R; Qi Z; Zhang K
Gene; 2013 Jul; 524(2):133-8. PubMed ID: 23628795
[TBL] [Abstract][Full Text] [Related]
12. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease.
Schipper HM; Liberman A; Stopa EG
Exp Neurol; 1998 Mar; 150(1):60-8. PubMed ID: 9514830
[TBL] [Abstract][Full Text] [Related]
13. Short (GT) ( n ) repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress.
Chen M; Zhou L; Ding H; Huang S; He M; Zhang X; Cheng L; Wang D; Hu FB; Wu T
Cell Stress Chaperones; 2012 May; 17(3):329-38. PubMed ID: 22120665
[TBL] [Abstract][Full Text] [Related]
14. Heme oxygenase microsatellite polymorphism, oxidative stress, glycemic control, and complication development in type 2 diabetes patients.
Choi SW; Yeung VT; Benzie IF
Free Radic Biol Med; 2012 Jul; 53(1):60-3. PubMed ID: 22583702
[TBL] [Abstract][Full Text] [Related]
15. Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurobiol Aging; 2012 Jul; 33(7):1485.e9-15. PubMed ID: 21130530
[TBL] [Abstract][Full Text] [Related]
16. ATXN8 -62 G/A promoter polymorphism and risk of Taiwanese Parkinson's disease.
Chen IC; Wu YR; Yang SJ; Kao SH; Chen YC; Chang KH; Lee CM; Lee-Chen GJ; Chen CM
Eur J Neurol; 2012 Nov; 19(11):1462-9. PubMed ID: 22577844
[TBL] [Abstract][Full Text] [Related]
17. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
Arch Gen Psychiatry; 2009 Jul; 66(7):721-8. PubMed ID: 19581563
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.
Venè R; Cardinali B; Arena G; Ferrari N; Benelli R; Minghelli S; Poggi A; Noonan DM; Albini A; Tosetti F
Neoplasia; 2014 Sep; 16(9):710-22. PubMed ID: 25246272
[TBL] [Abstract][Full Text] [Related]
19. Association of Polymorphism of Neuronal Nitric Oxide Synthase Gene with Risk to Parkinson's Disease.
Gupta SP; Kamal R; Mishra SK; Singh MK; Shukla R; Singh MP
Mol Neurobiol; 2016 Jul; 53(5):3309-3314. PubMed ID: 26081147
[TBL] [Abstract][Full Text] [Related]
20. Association of heme oxygenase-1 gene rs2071746 polymorphism with vascular outcomes in patients with atherosclerotic stroke.
Cao L; Zhang Z; Cai B; Bai W; Zhang Y; Sun W; Xie X; Sun W; Cai Q; Li Z; Liu D; Xiong Y; Ma M; Liu X; Xu G
J Neurol Sci; 2014 Sep; 344(1-2):154-7. PubMed ID: 25016572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
